Evidence map›Paper›PMID 41122026›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Quasi-Closed-Loop Crystal-Amorphous Solid-Wet Gel Transformation in Copper MOFs for Exceptional Cycling Stability in Cascade Reactions.

Jiaxuan Wu, Junting Hong, Zaikun Yan, Haidong Huang, Ziyuan Huang, Xihao Tang, Songliang Cai, Jun Fan, Weiguang Zhang, Yuwei Zhang and 1 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiaxuan Wu *GDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Junting Hong *GDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Zaikun YanGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Haidong HuangGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Ziyuan HuangGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Xihao TangGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Songliang CaiGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Jun FanGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Weiguang ZhangGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Yuwei ZhangGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.
Shengrun ZhengGDMPA Key Laboratory for Process Control and Quality Evaluation of Chiral Pharmaceuticals, and Guangzhou Key Laboratory of Analytical Chemistry for Biomedicine, School of Chemistry, South China Normal University, Guangzhou, 510006, China.ORCID https://orcid.org/0000-0002-9071-0748

Funding

National Natural Science Foundation of P. R. China 22073032National Natural Science Foundation of P. R. China 22122402National Natural Science Foundation of P. R. China 22171092National Natural Science Foundation of P. R. China 92356303Natural Science Foundation of Guangdong Province 2021A1515010211Natural Science Foundation of Guangdong Province 2022A1515011243Shenzhen Science and Technology Program CJGJZD20210408091800002
6 · The paper itself

Abstract

Quasi-closed-loop transformations between crystals, amorphous solids, and wet gels are rarely explored in metal-organic frameworks (MOFs). We report a stimuli-responsive Cu(I)-MOF (Cu-cMOF) constructed from relatively stable 1D Cu(I) secondary building units (s-SBUs) and unstable trigonal Cu(I) SBUs (us-SBUs). This unique architecture enables quasi-closed-loop crystal-amorphous solid-wet gel transformations through the following steps: i) The crystalline framework first undergoes oxidative amorphization via Cu(I)-to-Cu(II) conversion at us-SBUs, forming amorphous Cu-aMOF; ii) Cu-aMOF subsequently reorganizes into wet gel (Cu-MOG) in preheated DMAc via oxygen- and dimethylamine-assisted framework fragmentation and colloidal assembly; and iii) Cu-MOG transforms back to Cu-cMOF via a solvent-mediated phase transition. The relative structural persistence of the s-SBUs-in contrast to the labile us-SBUs-confers a degree of reversibility to the system. Remarkably, mutual regulation between reaction conditions and catalyst structure is achieved in the azidation-click cascade reaction. The azidation step drives the transformation of Cu-aMOF into Cu-cMOF, while the click reaction reverses this process. Each catalyst phase exhibits step-specific catalytic selectivity, forming a self-sustaining structural transformation cycle that maintains over 98% efficiency after at least 20 cycles. Additionally, used catalysts can be repurposed as Cu-MOGs for large-sized molecule adsorption. This work establishes a cooperative switchable system with adaptive multifunctionality.

Indexed as

AdsorptionCascade reactionMOFsStructural transformation

Identifiers

PMID41122026
PMCPMC13411214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.